RYVER.AI, a Munich, Germany-based health tech startup, has raised €1.3 million in financing. Read our article to learn more about how to raise seed funding for a startup.
The round was led by Nina Capital, a Spanish health tech VC, with participation from Bayern Kapital (Germany) and FundF (Austria).
Founded in 2019, Nina Capital is a venture capital investment firm based in Barcelona, Spain. The firm seeks to invest in the healthcare, data, computing, networks, digital, information, and deep technologies sectors.
RYVER.AI Use of Funds
The funds will be used for technical development, including hiring AI developers and investing in computing capacity to ensure high image quality. The startup aims to help medical AI providers generate diverse test and training data quickly and cost-effectively.
Founded by Kathrin Khadra, Simona Santamaria, and Jonas Ils, RYVER.AI develops generative models that enable medical AI developers to generate diverse sets of synthetic test and training data. RYVER.AI focused on addressing the lack of data for medical AI without compromising patient privacy. Their main focus is on the development of generative AI that creates datasets from radiological images such as CT, MRI, and X-ray.
Round: Pre-Seed Round
Funding Month: December 2023
Lead Investors: Nina Capital
Additional Investors: Bayern Kapital and FundF
Company Website: https://ryver.ai/
Software Category: Medical AI